Asia-Pacific radiotherapy market is projected to register a CAGR of 6.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
Asia-Pacific Radiotherapy Market By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/Radiopharmaceuticals & Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software & Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer & Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics & Others), Distribution Channel (Direct Tender, Retail Sales & Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines & Rest of Asia-Pacific) Industry Trends and Forecast to 2027
Some of the major factors contributing to the growth of the Asia-Pacific radiotherapy market are:
• Use of radiotherapy treatment in wide cancer applications
• Technology advance in radiotherapy products
Market Players:
The key market players for Asia-Pacific radiotherapy market are listed below:
• Varian Medical Systems, Inc.
• Mevion Medical Systems
• VIEWRAY TECHNOLOGIES, INC. (A Subsidiary of ViewRay)
• Siemens Healthcare GmbH
• Elekta AB
• Accuray Incorporated
• IBA Worldwide
• Eckert & Ziegler BEBIG
• RaySearch Laboratories
• Brainlab AG
• Koninklijke Philips N.V.
• GE Healthcare
• Hitachi, Ltd.
• Nordion (Canada) Inc.
• Sumitomo Heavy Industries, Ltd.